loadpatents
name:-0.018601894378662
name:-0.012197017669678
name:-0.0083310604095459
CHO; Joong Myung Patent Filings

CHO; Joong Myung

Patent Applications and Registrations

Patent applications and USPTO patent grants for CHO; Joong Myung.The latest application filed is for "pharmaceutical composition comprising hdac inhibitor and anti-pd1 antibody or anti pd-l1 antibody".

Company Profile
6.10.21
  • CHO; Joong Myung - Seoul KR
  • Cho; Joong Myung - Daejeon KR
  • Cho; Joong Myung - Moraga CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pharmaceutical Composition Comprising Hdac Inhibitor And Anti-pd1 Antibody Or Anti Pd-l1 Antibody
App 20220287993 - KIM; Young-Dae ;   et al.
2022-09-15
Injection Composition Containing Fab I Inhibitor, And Preparation Method Therefor
App 20220031607 - CHO; Jae Pyoung ;   et al.
2022-02-03
2,3-dihydro-isoindole-1-one derivative as BTK kinase suppressant, and pharmaceutical composition including same
Grant 11,230,539 - Hong , et al. January 25, 2
2022-01-25
Orally Administered Pharmaceutical Composition Comprising Fab I Inhibitors And Method For Preparing Same
App 20220016098 - CHO; Jae Pyoung ;   et al.
2022-01-20
Pharmaceutical Composition Containing Alkyl Carbamoyl Naphthalenyloxy Octenoyl Hydroxyamide Phosphate, Tartrate Or Combination Thereof, And Preparation Method Therefor
App 20210346321 - CHO; Jae Pyoung ;   et al.
2021-11-11
Pharmaceutical Composition, Comprising Polmacoxib And Pregabalin, For Treatment Of Pain
App 20210113515 - CHO; Jae Pyoung ;   et al.
2021-04-22
Pharmaceutical Composition For Prevention Or Treatment Of Fibrosis
App 20210015772 - CHO; Joong Myung ;   et al.
2021-01-21
2,3-dihydro-isoindole-1-one Derivative As Btk Kinase Suppressant, And Pharmaceutical Composition Including Same
App 20210009565 - HONG; Yong Rae ;   et al.
2021-01-14
Pharmaceutically Acceptable Salt Of Alkylcarbamoyl Naphthalenyloxy Octenoylhydroxyamide Or Of Derivative Thereof And Method For
App 20200283371 - Cho; Jae Pyoung ;   et al.
2020-09-10
Pharmaceutical Composition For Treating Acute And Chronic Pain, Containing Polmacoxib And Tramadol
App 20200276152 - CHO; Jae Pyoung ;   et al.
2020-09-03
2,3-dihydro-isoindole-1-one derivative as BTK kinase suppressant, and pharmaceutical composition including same
Grant 10,604,508 - Hong , et al.
2020-03-31
Oral pharmacological composition including 5-{4-(amino sulfonyl)phenyl}-2,2-dimethyl-4-(3-fluorophenyl)-3(2H)-furanone having crystalline structure with excellent stability
Grant 10,413,520 - Kim , et al. Sept
2019-09-17
Methods For Treating Patients With Hematologic Malignancies
App 20180344702 - RICE; William G. ;   et al.
2018-12-06
Oral Pharmacological Composition Including 5--2,2-Dimethyl-4-(3-Fluorophenyl)-3(2H)-Furanone Having Crystalline Structure With Excellent Stability
App 20180008571 - KIM; Byung-Ha ;   et al.
2018-01-11
2,3-dihydro-isoindole-1-one Derivative As Btk Kinase Suppressant, And Pharmaceutical Composition Including Same
App 20170362205 - Hong; Yong Rae ;   et al.
2017-12-21
2,3-dihydro-isoindole-1-on derivative as BTK kinase suppressant, and pharmaceutical composition including same
Grant 9,758,508 - Hong , et al. September 12, 2
2017-09-12
Pharmaceutical Composition Including 5--2,2-Dimethyl-4-(3-Fluorophenyl)-3(2H)-Furanone And Capsule Formulation Including The Pharmaceutical Composition
App 20170000759 - KIM; Byung-Ha ;   et al.
2017-01-05
2,3-dihydro-isoindole-1-on Derivative As Btk Kinase Suppressant, And Pharmaceutical Composition Including Same
App 20150336934 - HONG; Yong Rae ;   et al.
2015-11-26
Naphthalenyloxypropenyl derivatives having inhibitory activity against histone deacetylase and pharmaceutical composition comprising the same
Grant 8,053,435 - Lee , et al. November 8, 2
2011-11-08
Fab I inhibitor and process for preparing same
Grant 7,973,060 - Kim , et al. July 5, 2
2011-07-05
Pyridine Derivatives And Methods Of Use Thereof
App 20110028507 - Kim; Sun Nam ;   et al.
2011-02-03
2-aminoquinazoline Derivative
App 20100311965 - Sawa; Masaaki ;   et al.
2010-12-09
Naphthalenyloxypropenyl Derivatives Having Inhibitory Activity Against Histone Deacetylase And Pharmaceutical Composition Comprising The Same
App 20100069630 - Lee; Cheol Hae ;   et al.
2010-03-18
Imidazopyridine Derivatives Inhibiting Protein Kinase Activity, Method for the Preparation Thereof and Pharmaceutical Composition Containing Same
App 20090170847 - Lee; Seung Chul ;   et al.
2009-07-02
Sulfamide Derivatives and Pharmaceutical Composition for Upregulation of Lipid Metabolism Comprising Same
App 20070254882 - Cho; Joong Myung ;   et al.
2007-11-01
Fab I Inhibitor and Process for Preparing Same
App 20070135465 - Kim; Cheol Min ;   et al.
2007-06-14
Glycogen synthase kinase 3.beta. inhibitor, composition and process for the preparation thereof
Grant 7,179,832 - Cho , et al. February 20, 2
2007-02-20
Glycogen synthase kinase 3beta inhibitor, composition and process for the preparation thereof
App 20060079521 - Cho; Joong Myung ;   et al.
2006-04-13
Hepatitis C diagnostics and vaccines
Grant 6,538,126 - Cho , et al. March 25, 2
2003-03-25
Quillaja saponin adjuvant and vaccine formulation containing same
Grant 5,817,314 - So , et al. October 6, 1
1998-10-06
Endogenously sweetened transgenic plant products
Grant 5,739,409 - Fischer , et al. April 14, 1
1998-04-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed